MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$30,147K
Accounts receivable
$5,260K
Prepaid expenses and
other current assets
$2,801K
Inventory
$2,236K
Deferred r&d services,
current portion (note...
$1,958K
Collaboration revenue, billed
and unbilled
$137K
Total current assets
$42,539K
Deferred r&d services,
non-current portion (note...
$2,354K
Finance lease
right-of-use asset
$1,113K
Operating lease
right-of-use asset
$540K
Other non-current
assets
$376K
Property and equipment,
net
$209K
Total assets
$47,131K
Total liabilities and
stockholders (deficit)...
$47,131K
Total stockholders
(deficit) equity
$24,743K
Total liabilities
$22,388K
Accumulated deficit
-$324,913K
Additional paid-in capital
$349,654K
Total current
liabilities
$16,437K
R&d funding
liability (note 12)
$5,066K
Finance lease liability
$643K
Operating lease liability
$242K
Common stock, 0.0001
par value...
$2K
Accrued expenses and
other current...
$12,837K
Accounts payable
$2,072K
Deferred revenue
$782K
Finance lease liability
$405K
Operating lease liability
$341K
Back
Back
Balance Sheet
source: myfinsight.com
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)